Back to Trials
NCT05628974Recruiting

Normal Donor Blood Draws for Platelet Studies and Biomarker Evaluation (ND-PLT)

The Cleveland Clinic

Start Date

5/1/2020

Completion Date

6/30/2031

Summary

This is a single-center study at the Cleveland Clinic Main Campus designed to study biomarkers in healthy individuals to identify novel mechanisms of platelet activation and how platelets drive vascular inflammation and thrombosis in diseases.

Detailed Description

Our past studies have discovered novel platelet activation pathways that may be targets of therapeutic development. We have also defined an important role for a shift in platelet phenotype in vascular disease. Our studies use both in vivo animal models and validation using human platelets from isolated blood. Platelets from healthy individuals may be compared to patients with vascular diseases in the IRB approved protocol "Vascular Lab Resource" (IRB #19-1451) study which is actively recruiting patients at the Cleveland Clinic Main Campus and studies patients with vascular diseases.

Eligibility Criteria

Age Range: 18 years to 65 years

Inclusion Criteria: * Adults aged 18 to 65 years old * Healthy Male \& Female voluntary participants Exclusion Criteria: * Individuals who have taken anticoagulant or antiplatelet medications in past 10 days * Individuals with hematopoetic diseases

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Healthy

Locations

Cleveland Clinic

Cleveland, Ohio 44195

United States